Cost-effectiveness of In-shoe Pressure Measurement for Therapeutic Shoes
Launched by MAASTRICHT UNIVERSITY · Feb 11, 2014
Trial Information
Current as of June 09, 2025
Unknown status
Keywords
ClinConnect Summary
For each patient two pairs of shoes will be produced by two shoemakers, one using plantar pressure measurements and one according current standard production procedures. The patient will wear one of these two pairs of shoes during a period of 3 months.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • diabetes
- • neuropathy
- • prescription of therapeutic footwear
- • diabetic foot ulcer in the last 5 years
- • receiving regular preventive foot care
- • written informed consent
- Exclusion Criteria:
- • peripheral arterial disease
- • not motivated to wear therapeutic footwear
- • active foot ulcer
- • recent vascular intervention
- • severe mobility impairment
- • amputation more proximal than toes, except a single ray amputation is allowed.
- • severe visual impairment
- • active cancer
- • severe cardiac/ pulmonary failure
- • severe oedema
- • chronic drug abuse
- • severe psychiatric illness
- • hospital admission at the time of inclusion
- • any condition that may interfere with follow-up visits.
About Maastricht University
Maastricht University is a leading academic institution in the Netherlands, renowned for its innovative approach to research and education in the health sciences. With a strong emphasis on interdisciplinary collaboration, the university actively engages in clinical trials that aim to advance medical knowledge and improve patient outcomes. Maastricht University leverages its state-of-the-art facilities and expertise in various fields, including biomedical research, public health, and clinical practice, to conduct high-quality clinical studies that adhere to rigorous ethical standards. Committed to translating research findings into real-world applications, the university plays a pivotal role in addressing contemporary health challenges and enhancing healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Maastricht, , Netherlands
Sittard, , Netherlands
Patients applied
Trial Officials
Nicolaas C Schaper, PhD, MD
Principal Investigator
Maastricht University Medical Center
Hans H Savelberg, PhD
Study Director
Maastricht University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials